Telestroke Triage in Suspected Stroke Patients
ASTRAL
Ambulance Stroke Triage Assisted by Telemedicine (ASTRAL) Trial.
1 other identifier
interventional
484
1 country
1
Brief Summary
The ASTRAL trial is a randomized study in patients with suspected stroke in the ambulance setting. The study evaluates whether prehospital telestroke consultation, in addition to standard care, can reduce unnecessary stroke code activations and improve patient triage, treatment efficiency, and resource use. Participants are randomized to telestroke triage plus standard care or standard care alone. Outcomes include unnecessary stroke code activation, patient allocation, treatment times, functional outcome, safety, and cost-effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 23, 2026
June 1, 2026
1.3 years
June 5, 2026
June 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Appropriate Patient Allocation
Proportion of patients allocated to the appropriate level of care, including comprehensive stroke center, primary stroke center, or home discharge when clinically appropriate.
Immediately after the prehospital triage decision
Unnecessary Stroke Code Activation
Proportion of ambulance-suspected stroke patients in whom stroke code activation leads to in-hospital stroke team activation and CT scan preparedness, while final work-up shows no stroke or no indication for immediate neuro-intervention.
Through initial emergency department stroke evaluation
Study Arms (2)
Telestroke Triage + Standard Care
EXPERIMENTALAmbulance professionals receive real-time neurologist consultation via the SMART Triage platform in addition to standard prehospital stroke care.
Standard Care
ACTIVE COMPARATORRAV Hollands Midden triage protocol without telestroke consultation.
Interventions
Live tele-neurologist consultation via the SMART Triage platform during ambulance assessment of suspected stroke.
Usual prehospital stroke triage according to RAV Hollands Midden protocols without telestroke consultation.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Stroke code activation by ambulance professional during office hours
- Symptom onset \< 24 hours or uncertain onset
- The patient is deemed capable of understanding the study information and making a decision about participation/opt-out
You may not qualify if:
- \- Age under 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NyikaKruytlead
Study Sites (1)
Leiden University Medical Center
Leiden, South Holland, 2333 ZA, Netherlands
Related Publications (4)
Duvekot MHC, Venema E, Rozeman AD, Moudrous W, Vermeij FH, Biekart M, Lingsma HF, Maasland L, Wijnhoud AD, Mulder LJMM, Alblas KCL, van Eijkelenburg RPJ, Buijck BI, Bakker J, Plaisier AS, Hensen JH, Lycklama A Nijeholt GJ, van Doormaal PJ, van Es ACGM, van der Lugt A, Kerkhoff H, Dippel DWJ, Roozenbeek B; PRESTO investigators. Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study. Lancet Neurol. 2021 Mar;20(3):213-221. doi: 10.1016/S1474-4422(20)30439-7. Epub 2021 Jan 7.
PMID: 33422191BACKGROUNDBrauckmann V, Hudasch D, Graff P, Riecke T, Aktas G, Mayor J, Macke C. Prehospital neurological emergencies- a survey on the state of prehospital neurological assessment by emergency medical professionals. BMC Emerg Med. 2024 Sep 11;24(1):164. doi: 10.1186/s12873-024-01076-w.
PMID: 39256650BACKGROUNDNederlandse Vereniging voor Neurologie (NVN). Richtlijn Stroke 2021: Acute fase. Utrecht: NVN; 2021.
BACKGROUNDPowers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211. Epub 2019 Oct 30.
PMID: 31662037BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study is open-label for participants, ambulance professionals, and treating neurologists. Outcomes assessors for 3-month mRS and EQ-5D-5L assessments are blinded to treatment allocation
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 5, 2026
First Posted
June 18, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
June 23, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- IPD and supporting information will be available after publication of the primary results, beginning 6 months after publication and remaining available for 5 years.
- Access Criteria
- Access will be granted to qualified researchers who submit a scientifically sound proposal. Requests will be reviewed by the study team or data access committee, if applicable. Access requires a data use agreement and, where applicable, institutional ethics approval. Only de-identified data necessary for the approved analysis will be shared.
De-identified individual participant data (IPD) will be shared. The shared dataset will include variables needed to reproduce the primary and secondary analyses, such as baseline characteristics, treatment allocation, primary and secondary outcome variables, and key analysis covariates. Direct identifiers will not be shared. Data will be coded and pseudonymized.